A multi-institution phase II study of docetaxel and S-1 in combination with trastuzumab for HER2-positive advanced gastric cancer (DASH study)-Reference-Cited by-同舟云学术

A multi-institution phase II study of docetaxel and S-1 in combination with trastuzumab for HER2-positive advanced gastric cancer (DASH study)

Published:2017-12-30 Issue:2 Volume:81 Page:387-392
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Kagawa Shunsuke^ORCID,Muraoka Atsushi,Kambara Takeshi,Nakayama Hiroshi,Hamano Ryosuke,Tanaka Norimitsu,Noma Kazuhiro,Tanakaya Kohji,Kishimoto Hiroyuki,Shigeyasu Kunitoshi,Kuroda Shinji,Kikuchi Satoru,Kuwada Kazuya,Nishizaki Masahiko,Shirakawa Yasuhiro,Fujiwara Toshiyoshi

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/article/10.1007/s00280-017-3505-4/fulltext.html

Reference18 articles.

1. Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, Lordick F, Ohtsu A, Omuro Y, Satoh T, Aprile G, Kulikov E, Hill J, Lehle M, Ruschoff J, Kang YK, To GATI (2010) Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 376(9742):687–697. https://doi.org/10.1016/S0140-6736(10)61121-X

2. Pazo Cid RA, Anton A (2013) Advanced HER2-positive gastric cancer: current and future targeted therapies. Crit Rev Oncol Hematol 85(3):350–362. https://doi.org/10.1016/j.critrevonc.2012.08.008

3. Cornelison TL, Reed E (1993) Nephrotoxicity and hydration management for cisplatin, carboplatin, and ormaplatin. Gynecol Oncol 50(2):147–158. https://doi.org/10.1006/gyno.1993.1184

4. Bokemeyer C, Berger CC, Hartmann JT, Kollmannsberger C, Schmoll HJ, Kuczyk MA, Kanz L (1998) Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer. Br J Cancer 77(8):1355–1362

5. Leguy-Seguin V, Jolimoy G, Coudert B, Pernot C, Dalac S, Vabres P, Collet E (2007) Diagnostic and predictive value of skin testing in platinum salt hypersensitivity. J Allergy Clin Immunol 119(3):726–730. https://doi.org/10.1016/j.jaci.2006.11.640

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Biomarkers of Gastric Adenocarcinoma: Current Research and Future Perspectives;Cancers;2021-11-12

2. Dual-Energy CT–Based Nomogram for Decoding HER2 Status in Patients With Gastric Cancer;American Journal of Roentgenology;2021-06

3. Phase III Study to Evaluate Efficacy and Safety of Andecaliximab With mFOLFOX6 as First-Line Treatment in Patients With Advanced Gastric or GEJ Adenocarcinoma (GAMMA-1);Journal of Clinical Oncology;2021-03-20

4. Combination of trastuzumab and taxane-containing intensified chemotherapy in first-line treatment of HER2-positive advanced gastric cancer;Tumori Journal;2020-11-09

5. FOLFIRINOX for the Treatment of Advanced Gastroesophageal Cancers;JAMA Oncology;2020-08-01